PEARQ — Pear Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $0.00m
- -$31.82m
- $12.69m
Annual cashflow statement for Pear Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -9.33 | -97 | -65.1 | -75.5 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | -20.1 | 28 | -40.2 | -32.6 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -7.39 | 0.668 | -5.95 | -9.76 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -36.6 | -67.9 | -109 | -114 |
| Capital Expenditures | -0.281 | -3.9 | -4.63 | -3.47 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -40.3 | 62.8 | 7.51 | -5.99 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -40.6 | 58.9 | 2.88 | -9.46 |
| Financing Cash Flow Items | 0 | -1.5 | 143 | 0 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 12.7 | 91.7 | 164 | 2.15 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -64.5 | 82.7 | 57.9 | -121 |